Business

Return of the Billion Dollar Medtech Deal

MD+DI Managing Editor Omar Ford speaks out on the recent rash of billion-dollar deals medtech has seen during the COVID-19 era.

August 20, 2020

It seems as if today’s climate would call for smaller tuck-in deals. But the opposite is happening in the medical devices and diagnostics. The industry has seen larger more robust deals that are stretching past the billion-dollar mark.

Teladoc Health’s $16.5 billion bid to acquire Livongo holds the record of being one of the largest deals to be announced during the pandemic era (so far). The acquisition is fueled by the rise in demand for virtual health.

But more million-dollar deals beyond the virtual health space are happening – such as the proposed Siemens Healthineers/Varian merger.

MD+DI Managing Editor Omar Ford delves deeper to get to the bottom of this growing trend.

About the Author

Omar Ford

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

See more from Omar Ford

You May Also Like